KalVista Pharmaceuticals
KALV
#6541
Rank
$0.53 B
Marketcap
$10.71
Share price
-5.39%
Change (1 day)
-4.46%
Change (1 year)

Revenue for KalVista Pharmaceuticals (KALV)

Revenue in 2025 (TTM): N/A

In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for KalVista Pharmaceuticals from 2014 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) N/A
2024 N/A
2023 N/A
2022 N/A
2021 N/A-100%
2020 $3.82 M-67.57%
2019 $11.79 M-34.63%
2018 $18.04 M391.82%
2017 $3.66 M1263.57%
2016 $0.26 M827.59%
2015 $0.02 M0%
2014 $0.02 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA